Evaluation of side-effects of dexmedetomidine during endoscopic submucosal dissection

Evaluation of side-effects of dexmedetomidine during endoscopic submucosal dissection - Side-effects of dexmedetomidine during ESD

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000028767

Enrollment

120

Registered

2017-08-22

Start date

2017-08-22

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

neoplastic lesions of esophagus, stomach and colon

Interventions

Hydration with maintenance fluid only maintenance fluid

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients who undergo ESD (esophagus, stomach and colon) with using DEX

Exclusion criteria

Exclusion criteria: 1)uncontrollable diabetes 2)uncontrollable hypertension 3)uncontrollable heart disease 4)hypovolemic 5)severe or uncontroallable respiratory disease 6)acute alcoholoic addiction

Design outcomes

Primary

Measure	Time frame
Side-effects (hypotension, bradycardia, respiratory depression)	—

Countries

Japan

Contacts

Public ContactNaohiko Akimoto

Nippon Medical School Chiba-Hokuso Hospital Department of Gastroenterology

s03-004an@nms.ac.jp0476-99-1111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026